Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:ARYA

ARYA Sciences Acquisition Corp III (ARYA) Stock Price, News & Analysis

About ARYA Sciences Acquisition Corp III Stock (NASDAQ:ARYA)

Key Stats

Today's Range
$10.77
$11.25
50-Day Range
$9.91
$11.16
52-Week Range
$9.82
$25.89
Volume
366,228 shs
Average Volume
320,123 shs
Market Capitalization
$186.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ARYA Sciences Acquisition Corp III does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in New York, New York.

Receive ARYA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ARYA Sciences Acquisition Corp III and its competitors with MarketBeat's FREE daily newsletter.

ARYA Stock News Headlines

Oaktree Acquisition Corp. III Life Sciences (OACCU)
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
Mphasis appoints Ajay Arya to head M&A
Nautilus Biotechnology Inc (NAUT)
See More Headlines

ARYA Stock Analysis - Frequently Asked Questions

ARYA Sciences Acquisition Corp III (ARYA) raised $125 million in an IPO on Friday, August 7th 2020. The company issued 12,500,000 shares at a price of $10.00 per share. Jefferies and Goldman Sachs served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that ARYA Sciences Acquisition Corp III investors own include Ampio Pharmaceuticals (AMPE), bluebird bio (BLUE), Forte Biosciences (FBRX), Navidea Biopharmaceuticals (NAVB), Outlook Therapeutics (OTLK), Electrameccanica Vehicles (SOLO) and Sequential Brands Group (SQBG).

Industry, Sector and Symbol

Sector
N/A
Industry
Holding & Other Investment Offices
Sub-Industry
N/A
Current Symbol
NASDAQ:ARYA
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.30 per share

Miscellaneous

Free Float
N/A
Market Cap
$186.48 million
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:ARYA) was last updated on 12/23/2024 by MarketBeat.com Staff
From Our Partners